The Voya Corporate Leaders Trust: The Trust That Did Nothing Since 1935

In 1935, a group of investment managers created the Corporate Leaders Trust with a radical premise: select 30 of the best American blue-chip companies, invest equally in each, and then do nothing. Never rebalance. Never add or remove stocks. Never try to time the market. Just collect dividends and hold forever.

80 years later, in 2015, that original static portfolio had compounded to roughly $12 billion. An investor who invested $10,000 in 1935 would have $40+ million by 2015. The portfolio had survived the Great Depression, world wars, recessions, and market crashes, never changing, never "optimizing," just holding.

The Corporate Leaders Trust is perhaps the most literal proof of buy-and-hold discipline. It forced investors to hold, to never rebalance, to never tinker. And despite this rigidity (or perhaps because of it), the trust compounded to extraordinary returns, often beating actively managed portfolios.

Quick definition: The Corporate Leaders Trust, formed in 1935 with 30 dividend-paying stocks and never changed for 80 years, compounded to $12 billion through pure buy-and-hold discipline, proving that "do nothing" beats "do something" when something means frequent trading and market timing.

Key Takeaways

• A static portfolio of 30 blue-chip stocks from 1935, never rebalanced, achieved roughly 8–10% annualized returns over 80 years—competitive with actively managed portfolios
• The trust's dividend yield compounded as companies grew and paid more dividends; dividends became the primary driver of returns in later decades
• Rebalancing would have forced selling winners (AT&T, General Motors) and buying losers, reducing returns. Holding winners and letting losers lag was optimal
• The trust never had to chase trends, feared missing out, or made emotional decisions. Its mechanical constraints forced discipline
• By 2015, the trust's original portfolio had become a museum piece—some companies (like many industrials) had underperformed, others (like pharmaceuticals) had compounded dramatically

The Original Portfolio: 1935

In 1935, the Corporate Leaders Trust selected 30 companies it believed to be the strongest American businesses. The list included:

• Industrials: General Motors, General Electric, U.S. Steel, Du Pont, Alcoa
• Chemicals & Pharma: Dow Chemical, Eastman Kodak
• Utilities: AT&T, various regional power companies
• Oil: Standard Oil (predecessor to modern Exxon, Mobil, etc.)
• Finance: J.P. Morgan, Chase Bank
• Consumer: Coca-Cola, Colgate-Palmolive
• Food: Campbell Soup, Corn Products

These were the blue-chip giants of their era. Collectively, they represented the dominant American industries: manufacturing, utilities, oil, chemicals, and finance.

The Thesis

The trust's philosophy was simple: identify the strongest companies, weight them equally, and hold forever. The implicit thesis was:

1. These are the best companies: They will compound over decades
2. Diversification across 30 companies reduces risk: Even if some decline, others will grow
3. Doing nothing is better than tinkering: Avoiding trading and rebalancing saves costs and taxes
4. Dividends will compound: Over time, dividends reinvested will drive exponential returns

The Journey: 1935–2015 (80 Years)

Phase 1: The Depression and Recovery (1935–1945)

From 1935 to 1945, the trust held steady through the Depression, World War II, and recovery. Stock prices fluctuated wildly, but the trust never sold. Dividends continued being paid (though they were reduced during the Depression), and the trust reinvested all of them.

By 1945, the original 30 stocks had been battered but survived. The trust's discipline—not to panic, not to sell—proved valuable. Investors who had panic-sold stocks in 1932 and missed the recovery would have bitterly regretted it. The trust's forced holding prevented this mistake.

Phase 2: Post-War Growth (1945–1970)

From 1945 to 1970, American industrials boomed. General Motors, General Electric, U.S. Steel—these companies dominated global markets. The trust benefited enormously from this secular trend. Dividends grew, stock prices appreciated, and the trust compounded.

However, the trust's static composition meant it did not capture all of the era's growth. It missed the rise of new industries (early technology, plastics, pharmaceuticals' explosive growth). But it held the core of American industry, which was still powerful.

Phase 3: Inflation and Stagnation (1970–1980)

The 1970s were challenging. Inflation soared, corporate profit margins compressed, and real returns were minimal. The trust's holdings—heavy in industrials and utilities—suffered. But dividends continued to grow (nominally, even if real dividends stagnated).

The trust's static composition was now a disadvantage. It was overweight industrials and underweight growth sectors (technology, healthcare). An actively managed fund could have rotated into better-positioned sectors. But the trust held steady.

Phase 4: The Divergence Becomes Obvious (1980–2000)

From 1980 to 2000, the trust's static portfolio became increasingly anachronistic. Some holdings (like Coca-Cola, which was in some of the trust's variants) boomed. Others (industrial companies like U.S. Steel) declined as manufacturing moved overseas.

The trust did not rebalance. It did not sell the declining industrials to buy growing tech stocks. It simply held what it had—which meant it was overweight the past and underweight the future.

Despite this structural disadvantage, the trust compounded. Dividends from Coca-Cola, pharmaceuticals (if included), and financial services grew dramatically. The reinvested dividends purchased more shares, and the portfolio compounded.

Phase 5: The Modern Era (2000–2015)

By 2000–2015, the trust's original portfolio had become a historical curiosity. Some of the original companies no longer existed (merged, went bankrupt, or were spun off). Others had declined dramatically (auto manufacturers, steel companies).

Yet the trust's total value had still compounded to billions of dollars. The surviving companies (Coca-Cola, pharmaceutical companies, financial services) had grown so much that they offset the decline of others.

The Mathematics: Why a Static Portfolio Still Compounded

How did a portfolio that was "overweight the past and underweight the future" still compound to extraordinary returns?

Dividend reinvestment: The trust's dividend yield remained high (even as growth stocks paid low dividends). These dividends were reinvested, purchasing more shares. Over 80 years, dividend reinvestment compounded dramatically.

Survivor bias: While some original companies declined, many survived and grew. Coca-Cola, for instance, compounded from a $50 stock to a $600+ stock. This 12x appreciation, combined with dividend reinvestment, created enormous wealth.

No rebalancing drag: Here's the crucial insight: the trust's refusal to rebalance was a feature, not a bug. If the trust had rebalanced (selling winners like Coca-Cola to buy losers like U.S. Steel), it would have forced selling winners and buying declining companies. This would have reduced returns.

By holding without rebalancing, the trust implicitly "held winners and let losers go to zero." This is the optimal strategy for picking stocks (which the trust had done well in 1935). But it only works if you hold the winners without selling.

Fee efficiency: The trust's static nature meant minimal turnover, minimal trading costs, and minimal fees. It had no fund managers actively trading. This cost advantage, compounded over 80 years, was significant.

The Lesson: Stocks Picked Well in 1935 Were Still Holding Up in 2015

The critical insight is that the trust's managers had picked well in 1935. They had selected genuinely strong companies. While the world changed dramatically—manufacturing moved overseas, technology emerged, industries shifted—the original 30 companies (or their successors) remained valuable.

This teaches a lesson about stock picking: if you pick genuinely strong companies at reasonable valuations, and you hold them for decades through all market cycles, you can achieve competitive returns without any subsequent active management.

The trust was not lucky; it was disciplined. And discipline, combined with good initial stock picks, compounds to extraordinary returns.

What If the Trust Had Rebalanced?

Here's a fascinating counterfactual: what if the Corporate Leaders Trust had rebalanced annually?

If the trust had rebalanced (maintaining 30 equal-weight stocks), it would have:

• Sold winners like Coca-Cola when they became 10–20% of the portfolio, locking in gains but missing future appreciation
• Bought losers like U.S. Steel when they had declined, catching the falling knife and realizing losses
• Incurred taxes from selling winners; in taxable accounts, this drag would be significant

The result: a rebalanced version of the trust likely would have returned 6–8% annualized, vs. the non-rebalanced trust's 8–10%. Rebalancing would have cost 2% annually, compounded over 80 years, costing investors hundreds of millions of dollars.

This is a powerful lesson: rebalancing is often presented as prudent risk management. But if you have picked strong companies and held them through bull and bear markets, rebalancing forces you to sell winners and buy losers—mechanically reducing returns.

The Trust's Composition Today: A Museum of History

By 2015, the trust's original portfolio had evolved. Some original companies had merged or gone bankrupt. Others had spun off divisions. But the core holdings represented:

• Pharmaceutical winners: Companies that benefited from drug innovation
• Financial survivors: Banks that weathered crises
• Consumer staples: Coca-Cola, consumer goods companies with pricing power
• Declining industrials: U.S. Steel, other manufacturers, which were smaller but still held

The trust was a museum of 80 years of capitalism. It held the winners (Coca-Cola), the survivors (banks), and the losers (steel). This mix, held without rebalancing, had compounded to extraordinary returns.

Common Mistakes: What Investors Did Differently

Rebalanced too frequently: Many investors who mimicked the trust's concept but rebalanced annually missed the explosive returns from not selling winners. Rebalancing was the mistake.

Abandoned the strategy during downturns: In 2000–2002 (dot-com crash), 2008–2009 (financial crisis), many investors would have questioned their static portfolio and made changes. The trust's structure forced holding.

Tried to add new companies: If an investor had wanted to "update" the trust's portfolio with tech stocks in the 1980s or 1990s, they would have had to sell winners. This would have been a mistake.

Took profits too early: Some investors who held the trust's stocks (or similar) might have sold after 5x or 10x gains. The 80-year compounding only happened because investors held.

Paid fees that eroded returns: An investor who held the same 30 stocks without a fund manager structure would have saved 0.5–1% annually in fees, accelerating compounding.

FAQ

Q: Was the trust's success just luck? What if it had picked bad companies? A: Partly the trust's managers were skilled in 1935; they picked genuinely strong companies. If they had picked weak ones, the trust would have performed poorly. But luck plays a role in any long-term holding (which companies survive, which thrive). The discipline to hold was non-negotiable; the luck was in picking well initially.

Q: Would a modern investor replicate this trust's success today? A: Uncertain. The trust picked in 1935 at valuations (8–10x earnings) that offered room for multiple expansion. Today, at 20x earnings, there is less multiple expansion available. However, dividend reinvestment and long-term compounding still work. A modern static portfolio might return 6–8% instead of 8–10%, but compounding over 50+ years still builds wealth.

Q: Why didn't the trust rebalance and update its holdings? A: By design. The trust was meant to test whether a static, never-rebalanced portfolio could succeed. It could. Rebalancing would have been a different strategy with different results.

Q: Did the trust ever suspend dividend reinvestment? A: No. Dividends were automatically reinvested, forcing discipline and maximizing compounding. If an investor had taken the dividends as cash, terminal wealth would have been much lower.

Q: How did the trust handle stock splits? A: Stock splits mechanically increased share count without affecting ownership. When a company split 2-for-1, an investor's 100 shares became 200. The trust's holdings increased proportionally.

Q: What happened to the trust after 2015? A: The trust continued to exist and evolved. Some original holdings were removed or modified as the structure was updated. But the core lesson—buy strong companies and hold—remained.

Real-World Examples

Example 1: The Static Trust (Corporate Leaders Trust Path) Invest $10,000 in 1935 in 30 equal-weight blue-chip stocks. Never rebalance. Reinvest all dividends. Hold 80 years. By 2015, portfolio is worth $30+ million. This is the trust's actual result.

Example 2: The Rebalanced Portfolio (Alternative) Invest $10,000 in 1935 in 30 equal-weight blue-chip stocks. Rebalance annually to maintain equal weight. Reinvest dividends. This forces selling winners (Coca-Cola) and buying losers (U.S. Steel). Over 80 years, returns are estimated at 6–8% annualized instead of 8–10%. Terminal wealth: $10–15 million instead of $30 million.

Example 3: The Active Trader (Cautionary Tale) Invest $10,000 in 1935, but try to optimize the portfolio every year, selling underperformers and buying perceived winners. Incur taxes, trading costs, and fees. Fail to capture the long-term winners' explosive growth. Over 80 years, returns might be 5–6% annualized. Terminal wealth: $3–5 million instead of $30 million.

Related Concepts

• Static portfolio strategy: Maintaining a fixed allocation without rebalancing
• Dividend reinvestment: The engine of the trust's compounding
• Buy and hold excellence: The trust was the ultimate buy-and-hold vehicle; it forced excellence through structure
• Rebalancing drag: The cost of selling winners to buy losers, mechanically reducing returns
• Survivor bias: The trust's compounding reflected surviving companies' growth, offset by losing ones' decline
• Fee efficiency: Minimal turnover meant minimal costs, accelerating compounding
• Multiple expansion: The trust's 80-year hold captured multiple expansion (valuations rising as confidence returned) as a source of returns

Summary

The Corporate Leaders Trust is the ultimate buy-and-hold case study. Formed in 1935 with 30 equal-weight, blue-chip stocks and never changed, it compounded to $12 billion over 80 years through pure discipline.

Key lessons:

1. Good stock picks held forever beat frequent trading: The trust's managers picked well in 1935 and never sold. This forced discipline delivered 8–10% annualized returns—competitive with active management—without the costs of active management.

2. Rebalancing forces you to sell winners and buy losers: The trust's refusal to rebalance meant it held winners (Coca-Cola) while letting losers (U.S. Steel) become smaller positions. This was optimal.

3. Static portfolios are underappreciated: Modern portfolio theory emphasizes rebalancing, diversification, and active management. The trust proved that a static, never-updated portfolio can deliver excellent long-term returns.

4. Dividend reinvestment is the engine: The trust's compounding came primarily from reinvested dividends, not from spectacular price appreciation or active management.

5. Time and discipline matter more than optimization: The trust did not optimize. It just held. Over 80 years, discipline compounded to extraordinary returns.

6. Forcing constraints improves behavior: The trust's structure forced investors to hold. This forced discipline is often more valuable than active management.

The Corporate Leaders Trust proves that if you pick strong companies and hold them forever, compounding will deliver returns that beat active management—despite not actively managing at all.

Next Steps

To understand how to select compounding stocks worthy of permanent holding, see What is a Compounder?. For strategies to reinvest dividends efficiently, see The Role of Dividends Over Time. And for more lessons from real-world portfolio studies, continue to Peter Lynch's Magellan Fund Run.